India has made commendable progress within the struggle in opposition to AIDS, however now’s the time to take this even additional by way of offering pre-exposure prophylaxis (PrEP) and main world efforts in direction of self-funded sustainable options, stated a press launch from the Indian AIDS Society, knowledgeable affiliation of HIV therapy docs and researchers.
The United Nations estimates that 40.8 million persons are dwelling with HIV worldwide. Of those, 2,544,000 are in India. In 2024, India reported 68,450 new instances.
At this time, with the provision of highly effective antiretroviral remedy (ART), research have proven that individuals with HIV who’ve entry to those medicine don’t develop AIDS, and that individuals on ART who’re virologically suppressed have a life expectancy much like that of individuals with out HIV.
new antiviral medicine
Though there isn’t any vaccine to forestall HIV an infection, a brand new long-acting injectable antiviral drug, lenacapavir, can now forestall HIV when given twice a 12 months as pre-exposure prophylaxis (PrEP).
Nevertheless, India has not but applied PrEP and this hole must be mounted to realize zero new infections. The report quotes UNAIDS Govt Director Winnie Byanyima as saying: “The HIV response has already saved 26.9 million lives all over the world. An HIV prevention revolution might finish AIDS as a public well being menace and save many extra lives.”
By way of funding, the US withdrawal disrupted therapy and prevention packages all over the world in early 2025.
In India, 95% of funding for HIV therapy and prevention is offered via the federal government. India can lead world efforts to assist low- and middle-income international locations take duty for themselves and assist HIV prevention and therapy efforts via sustainable, complete and multi-sectoral options which can be country-owned and led, the discharge stated. stated N. Kumarasamy, vice-president of the Indian AIDS Society.
